Vaccinex Prices $9.6M Public Offering Of 9.6M Common Shares And Warrants At $1/Share
Portfolio Pulse from Benzinga Newsdesk
Vaccinex has announced a public offering of 9.6 million common shares and warrants at $1 per share. The offering includes significant participation from an entity affiliated with the Chairman of the Company's Board of Directors, and existing investors. The warrants will have an exercise price of $1.00 per share, will be immediately exercisable and will expire five years from the initial exercise date.

September 29, 2023 | 7:07 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Vaccinex's public offering of 9.6 million shares and warrants at $1 per share may dilute existing shareholders' equity, potentially leading to a short-term decrease in stock price.
Public offerings often lead to dilution of existing shareholders' equity, which can result in a decrease in stock price. Given the size of the offering and the price per share, this could have a significant impact on Vaccinex's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100